SourceX Dashboard
Pre-IPO · Private Placement

The SourceX Pre-IPO
Private Placement is coming

Two private rounds before a planned public listing. Round 1 — Founder's Tier subscription opens July 1, 2026.

$0 raised of $10M
$10M
remaining
0% funded Round 1 · target $10M
View prospectus
Round 1 opens in
--
Days
--
Hours
--
Min
--
Sec
What is this — in 30 seconds

A chance to invest in SourceX, the company — buying actual shares (equity) before it plans to list on a public stock exchange. This is not a trading or savings package; you become a part-owner. Early rounds are priced well below the planned IPO price.

1
Buy shares early
Round 1 opens July 1, 2026 at $6.50/share (min. $25,000).
2
Company grows
Two private rounds fund growth toward a planned 2028 public listing.
3
Public IPO (2028)
Shares may then list at $22–28 — if and when the IPO occurs.

Investing in a company is high-risk; returns are not guaranteed and the listing may not happen. Qualified investors only.

Traction at a glance
0
Institutional clients
0
Individual users
0
ARR
0
Monthly growth
0
Uptime SLA
0
Insurance

Figures are management's stated metrics from the offering document. They are not audited here and are not a promise of future performance.

Funding roadmap 2026–2028
OPENS JULY 1
Round 1 · Founder's Tier
$6.50/share
July 2026 · target $10M · post-money $130M
Subscription July 1–31, 2026
Minimum $25,000 · Common Stock
Maximum benefits tier
Round 2 · Growth Tier
$9.00/share
December 2026 · target $20M · post-money $200M
Subscription Dec 1–31, 2026
Minimum $50,000 · +38% vs Round 1
Payment card live milestone
Public IPO
$22–28/share
Q2–Q3 2028 · target $900M–$1.1B
Planned Nasdaq Dubai / Euronext
Subject to market & regulatory approval
Listing is not guaranteed
Round 1 — Founder's Tier highlights
Health insurance — 3 years

Comprehensive medical, dental, vision & wellness coverage for Round 1 investors for three years (stated value $54K–$75K). Coverage and eligibility per the offering document.

Investment cover — Round 1 (separate)

Every Round 1 (first-round) investor also receives a separate insurance benefit for their investment, in addition to the health insurance. Coverage scope, limits and eligibility are defined by the offering and applicable policy terms; it does not guarantee returns or protect against all losses.

Token allocation

Up to 40% discount on the token platform.

Revenue share

Revenue-sharing participation per terms.

Premium card

Premium card & rewards programme.

Equity rights

Voting, pro-rata & standard protections.

Board observer

For $500K+ investments (observer).

Liquidation pref.

1× non-participating.

What your shares could be worth

Illustrative only — based on the planned 2028 IPO price range. Not a guarantee; the listing may not happen.

You investShares (@ $6.50)At IPO $22At IPO $28
$25,0003,846$84,600$107,688
$50,0007,692$169,200$215,376
$100,00015,385$338,400$430,752
$250,00038,462$846,000$1,076,936
More than shares — the SourceX ecosystem

During the IPO, investors also unlock member benefits across the companies SourceX invests in — travel, health, finance and lifestyle partners.

Flights
Discounted air tickets
Travel
Hotels & holiday packages
Hospital
Priority private clinics
Surgery
Elective & medical procedures
Insurance
Health & life cover
Banking
Premium accounts & cards
Shopping
Partner-store discounts
…and more
New partners added over time

Benefit availability and eligibility depend on the offering terms and partner agreements; perks may change over time.

Important — high-risk investment

This page is informational only and is not an offer to sell or a solicitation to buy securities. Any investment is made solely under the official offering documents and only where lawful. Securities of this kind are high-risk and illiquid; you may lose your entire investment. Projected figures and share prices are the company's estimates, not guarantees, and any public listing may not occur. Participation may be restricted to qualified / accredited investors and by your jurisdiction. Seek independent financial and legal advice. See the Terms.

Full prospectus

The full document is marked “Confidential — Qualified Investors Only.” Please confirm your status to view it.

© 2026 SourceX Asset Management LLC · Confidential — Qualified Investors Only · Terms · Privacy